020 3312 6876

Becci Flitt, secretary

020 3312 1253

Claudette Lynch, secretary


Professor Jonathan Valabhji is national clinical director for diabetes and obesity at NHS England. He is a consultant diabetologist at St Mary’s Hospital, Imperial College Healthcare NHS Trust and so remains highly active at the clinical coalface. The published clinical outcomes from his multidisciplinary diabetic foot service at the Trust are comparable to the best centres internationally. He is professor of practice (diabetes) at Imperial College London, with a current research focus on diabetic foot disease as well as on diabetes population level health.

As national clinical director, he is clinical lead for the NHS England Diabetes Programme, including both the diabetes treatment and care programme and the Healthier You: NHS diabetes prevention programme, a collaboration between NHS England, Public Health England and Diabetes UK that in Summer 2018 saw England become the first country in the world to achieve full national coverage with an evidence-based Type 2 diabetes prevention programme.

He qualified in 1990 from St Bartholomew’s Hospital Medical College, London. He was awarded OBE for services to diabetes and obesity care in the 2019 New Year Honours List.



Diabetes, diabetic foot disease, Type 1 diabetes

Research & publications

Clift AK, Coupland CAC, Keogh R, Diaz-Ordaz K, Williamson E, Harrison EM, Hayward A, Hemingway H, Horby P, Mehta N, Benger J, Khunti K, Spiegelhalter D, Sheikh A, Valabhji J, Lyons RA, Robson J, Semple C, Kee F, Kohnson P, Jebb S, Williams T, Hippisley-Cox J. QCOVID risk prediction algorithm for risk of hospitalisation and mortality from COVID-19 in adults: national derivation and validation cohort study. BMJ 2020; Oct 20;371:m3731. doi: 10.1136/bmj.m3731.

Barron E, Misra S, English E, John WG, Sampson M, Bachmann M, Barth JH, Oliver N, Alberti G, Bakhai C, O’Neill S, Young B, Wareham NJ, Khunti K, Jebb S, Smith J, Valabhji J. Experience of Point-of-Care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study. BMJ Open Diabetes Res Care. 2020; In Press.

Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 2020;8(10):813-822.

Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 2020;8(10):823-833.

Palladino R, Tabak AG, Khunti K, Valabhji J, Majeed A, Millett C, Vamos EP. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes. BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001061.

Valabhji J. Rapid access to multidisciplinary diabetes foot care teams. BMJ. 2020 Mar 4;368:m773. doi: 10.1136/bmj.m773.

Misra S, Hassanali N, Bennett AJ, Juszczak A, Caswell R, Colclough K, Valabhji J, Ellard S, Oliver NS, Gloyn AL. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulphonylurea-Sensitive Diabetes. Diabetes Care. 2020 Apr;43(4):909-912.

Valabhji J, Barron E, Bradley D, Bakhai C, Fagg J, O’Neill S, Young B, Wareham N, Khunti K, Jebb S, Smith J. Early outcomes from the English National Health Service Diabetes Prevention Programme, Diabetes Care 2020; 43: 152-160.

McGough B, Murray E, Brownlee L, Barron E, Smith J, Valabhji J. The Healthier You: NHS Diabetes Prevention Programme: digital modes of delivery engage younger people. Diabet Med 2019; 36: 1510-1511.

Murray E, Daff K, Lavida A, Henley W, Irwin J, Valabhji J. Evaluation of the digital diabetes prevention programme pilot: uncontrolled mixed-methods study protocol. BMJ Open 2019; 9: e025903.

Taylor R, Valabhji J, Aveyard P, Paul D. Prevention and reversal of Type 2 diabetes: highlights from a symposium at the 2019 Diabetes UK Annual Professional Conference. Diabet Med 2019; 36: 359-365.

Fagg J, Valabhji J. How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing? Diabet Med 2019; 36: 316-325.

National public health system responses to diabetes and other important noncommunicable diseases : Background, goals, and results of an international workshop at the Robert Koch Institute.
Reitzle L, Hansen S, Paprott R, Achtermann W, Baumert J, Bogaert P, Curt L, Diem P, Du Y, Eiser S, Fitzpatrick J, Heidemann C, Jousilahti P, Kulzer B, Lindström J, Neuhauser H, van Oyen H, Pelletier L, Schmidt C, Valabhji J, Weitgasser R, Ziese T, Zahn D, Scheidt-Nave C.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct;61(10):1300-1306. doi: 10.1007/s00103-018-2806-z. Review.
PMID: 30191268

Financial disincentives? A three-armed randomised controlled trial of the effect of financial Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial.
Judah G, Darzi A, Vlaev I, Gunn L, King D, King D, Valabhji J, Bicknell C.
Br J Ophthalmol. 2018 Aug;102(8):1014-1020. doi: 10.1136/bjophthalmol-2017-311778. Epub 2018 May 23.
PMID: 29793929

Type 2 diabetes mellitus in older people: a brief statement of key principles of modern day management including the assessment of frailty. A national collaborative stakeholder initiative.
Strain WD, Hope SV, Green A, Kar P, Valabhji J, Sinclair AJ.
Diabet Med. 2018 Jul;35(7):838-845. doi: 10.1111/dme.13644. Epub 2018 May 6. Review.
PMID: 29633351

Progress of the Healthier You: NHS Diabetes Prevention Programme: referrals, uptake and participant characteristics.
Barron E, Clark R, Hewings R, Smith J, Valabhji J.
Diabet Med. 2018 Apr;35(4):513-518. doi: 10.1111/dme.13562. Epub 2017 Dec 28.
PMID: 29266374

Using data to tackle the burden of amputation in diabetes.
Jeffcoate W, Barron E, Lomas J, Valabhji J, Young B.
Lancet. 2017 Oct 21;390(10105):e29-e30. doi: 10.1016/S0140-6736(17)32401-7. Epub 2017 Sep 11. No abstract available.
PMID: 28911921

Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial: a three-armed randomised controlled trial of financial incentives.
Judah G, Darzi A, Vlaev I, Gunn L, King D, King D, Valabhji J, Bishop L, Brown A, Duncan G, Fogg A, Harris G, Tyacke P, Bicknell C.
Southampton (UK): NIHR Journals Library; 2017 Mar.
PMID: 28375591

Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.
Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C.
CMAJ. 2016 Oct 4;188(14):E342-E351. Epub 2016 Jul 25.
PMID: 27455981

Incentives in Diabetic Eye Assessment by Screening (IDEAS): study protocol of a three-arm randomized controlled trial using financial incentives to increase screening uptake in London.
Judah G, Vlaev I, Gunn L, King D, King D, Valabhji J, Darzi A, Bicknell C.
BMC Ophthalmol. 2016 Mar 18;16:28. doi: 10.1186/s12886-016-0206-4.
PMID: 26993471

Rachel Clark and colleagues reply to Eleanor Barry and colleagues.
Clark R, Valabhji J, Tedstone A, Ansari L, O'Brien J.
BMJ. 2015 Oct 8;351:h5301. doi: 10.1136/bmj.h5301. No abstract available.
PMID: 26451005

Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Newton JN, Briggs AD, Murray CJ, Dicker D, Foreman KJ, Wang H, Naghavi M, Forouzanfar MH, Ohno SL, Barber RM, Vos T, Stanaway JD, Schmidt JC, Hughes AJ, Fay DF, Ecob R, Gresser C, McKee M, Rutter H, Abubakar I, Ali R, Anderson HR, Banerjee A, Bennett DA, Bernabé E, Bhui KS, Biryukov SM, Bourne RR, Brayne CE, Bruce NG, Brugha TS, Burch M, Capewell S, Casey D, Chowdhury R, Coates MM, Cooper C, Critchley JA, Dargan PI, Dherani MK, Elliott P, Ezzati M, Fenton KA, Fraser MS, Fürst T, Greaves F, Green MA, Gunnell DJ, Hannigan BM, Hay RJ, Hay SI, Hemingway H, Larson HJ, Looker KJ, Lunevicius R, Lyons RA, Marcenes W, Mason-Jones AJ, Matthews FE, Moller H, Murdoch ME, Newton CR, Pearce N, Piel FB, Pope D, Rahimi K, Rodriguez A, Scarborough P, Schumacher AE, Shiue I, Smeeth L, Tedstone A, Valabhji J, Williams HC, Wolfe CD, Woolf AD, Davis AC.
Lancet. 2015 Dec 5;386(10010):2257-74. doi: 10.1016/S0140-6736(15)00195-6. Epub 2015 Sep 14.
PMID: 26382241

Gibbons DC, Soljak MA, Millett C, Valabhji J, Majeed A, (2014), Use of hospital admissions data to quantify the burden of emergency admissions in people with diabetes mellitus. Diabetic Medicine, 31 971-975. Impact Factor (IF): 2.902

Calderon-Larranaga A, Soljak M, Cecil E, Valabhji J, Bell D, Prados Torres A, Majeed A, (2014), Does higher quality of primary healthcare reduce hospital admissions for diabetes complications? A national observational study. Diabet Med., 31 657-665. IF: 2.902.

Valabhji J, Marshall RC, Lyons S, Bloomfield L, Hogg D, Rosenfeld P, Gabriel CM, (2012), Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy. Diabetic Medicine, 29(9): 1191-1194. IF: 2.902

Patel DC, Albrecht C, Pavitt D, Paul V, Pourreyron C, Newman SP, Godsland IF, Valabhji J, JohnstonDG, (2011), Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLoS One., 6(7): e22142. IF: 4.090

J Valabhji, (2011), Immunosuppression therapy post-transplantation can be associated with a different clinical phenotype for diabetic charcot foot neuroarthropathy. Diabetes Care, 34 e135. IF: 8.087

Fikri R, Bicknell C, Bloomfield L, Lyons S, Samarasinghe D, Gibbs RGJ, Valabhji J, (2011), Awaiting auto-amputation: a primary management strategy for digital gangrene in diabetic foot disease. Diabetes Care, 34 e134. IF: 8.087

J Valabhji, RGJ Gibbs, L Bloomfield, S Lyons, D Samarasinghe, P Rosenfeld, CM Gabriel, D Hogg, CD Bicknell, (2010), Matching the numerator with an appropriate denominator to demonstrate low amputation incidence associated with a London hospital multidisciplinary diabetic foot clinic. Diabetic Medicine, 27 1304-1307. IF: 2.902.

Vamos EP, Bottle A, Edmonds ME, Valabhji J, Majeed A, Millett C, (2010), Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care, 33: 2592-2597. IF: 8.087

Thorning C, Gedroyc WMW, Tyler PA, Dick EA, Hui E, Valabhji J (2010), Midfoot and hindfoot bone marrow oedema identified by magnetic resonance imaging in feet of subjects with diabetes and neuropathic ulceration is common but of unknown clinical significance. Diabetes Care, 33 1602-1603. IF: 8.087

Valabhji J, Oliver N, Samarasinghe D, Mali T, Gibbs RGJ, Gedroyc WMW (2009), Conservative management of diabetic forefoot ulceration complicated by underlying osteomyelitis: the benefits of magnetic resonance imaging. Diabetic Medicine; 26: 1127 -1134. IF: 2.902

Yee MS, Pavitt DV, Richmond W, Cook HT, McLean AG, Valabhji J, Elkeles RS, (2009), Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis; 205(2):528-32. IF: 3.794

George PM, Valabhji J, Dawood M, Henry JE (2005), Screening for Type 2 diabetes in the accident and emergency department. Diabetic Medicine, 22 (12): 1766-1769. IF: 2.902

Albrecht C, Simon-Vermot I, Elliot JI, Higgins CF, Johnston DG, Valabhji J, (2004), Leukocyte ACBA1 gene expression is associated with fasting glucose concentration in normoglycaemic men. Metabolism, 53 (1): 17-21. IF: 2.664

Valabhji J, Watson M, Wassouf S, Bridges N, Poulter C, Elwig C, Cox J, Robinson S, Elkeles RS, (2003), Type 2 Diabetes presenting as Diabetic Ketoacidosis in Childhood. Diabetic Medicine 20: 416-417. IF: 2.902

Valabhji J, Donovan J, McColl AJ, Schachter M, Richmond W, Elkeles RS, (2002), Rates of cholesterol esterification and esterified cholesterol net mass transfer in type 1 diabetes. Diabetic Medicine 19 (5): 424-428. IF: 2.902

Valabhji J, McColl AJ, Schachter M, Richmond W, Elkeles RS, (2001), High-density lipoprotein composition and paraoxonase activity in type 1 diabetes. Clinical Science 101: 659-670. IF: 4.317

Valabhji J, McColl AJ, Richmond W, Schachter M, Rubens M, Elkeles RS, (2001), Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 24 (9): 1608-1613. IF: 8.087

Valabhji J, Donovan J, Kyd PA, SchachterM, Elkeles RS, (2001), The relationship between active renin concentration and plasma renin activity in type 1 diabetes. Diabetic Medicine 18 (6): 451-458. IF: 2.902

Valabhji J, Dhanjil S, Nicholaides AN, Elkeles RS, Sharp P (2001), Correlation between carotid artery distensibility and serum vascular endothelial growth factor (VEGF) concentrations in type 1 diabetic and non-diabetic subjects. Metabolism, 50 (7): 825-829. IF: 2.664

Valabhji J, Robinson S, Poulter C, Robinson ACJ, Kong C, Henzen C, Gedroyc WMW, Feher MD, Elkeles RS (2000), Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care 23: 539-543. IF: 8.087

Sharp PS, Al-Mrayat M, Valabhji J, Kearney TM, Wright D, (1998), Serum levels of vascular endothelial growth factor in diabetic subjects: the relationship with blood pressure. Diabetologia 41 (8): 984. IF: 6.814

Remedios D, Valabhji J, Oelbaum R, Sharp P, Mitchell R, (1998), 99mTc-Nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet. Clinical Radiology 53 (2): 120-125. IF: 1.665

Valabhji J, (Dec 2013), Excess inpatient mortality for those with diabetes in England. Diabetic Medicine; 30(12):1391-2. IF: 2.902

Valabhji J, Elkeles RS, (2001), Type 1 diabetes and ageing: does LDL oxidation mediate their associations with coronary heart disease? European Heart Journal 22: 2045-2047. IF: 10.478

Valabhji J, Robinson S (2001), Diabetes and lipids - a conundrum. Diabetic Medicine 18: 250. IF: 2.902

Robinson S, Valabhji J, Schachter M, (2001), NICE's guidance suggests using rosiglitazone in type 2 diabetes later than is ideal. British Medical Journal 322: 491. IF: 14.093

Sood HS, Maruthappu M, Valabhji J, (2015), The National Diabetes Prevention Programme: a pathway for prevention and wellbeing. Br J Gen Pract. 65 336-337

Jeffcoate W, Holman N, Rayman G, Valabhji J, Young B (2014), The New National Diabetes Footcare Audit of England and Wales. Diabetic Med. In Press. IF: 2.902

Valabhji J, (2012), Foot problems in patients with diabetes and chronic kidney disease. Journal of Renal Care Feb;38 Suppl 1:99-108. doi: 10.1111/j.1755-6686.2012.00284.x

Valabhji J, (2011), Reducing Amputations at a multidisciplinary diabetic foot clinic. The Diabetic Foot Journal 14 82-87

Levy MJ, Valabhji J (2008), The diabetic foot. Surgery 26 (1): 25-28

Valabhji J, Elkeles RS,(2002), Non-invasive measurement of coronary heart disease using electron beam computed tomography. Current Opinions in Lipidology 13 (4): 409-414. IF: 6.086

Valabhji J, Elkeles RS, (2002), Macrovascular disease in diabetes. Medicine 2002 30 (2): 47-50

Valabhji J, Elkeles RS (2000), Are surrogate end-point studies worth the effort? Current Controlled Trials in Cardiovascular Medicine 1: 72-75. IF: 2.330

Amin T, Poon LC, Teog TG, Moorthy K, Robinson S, Neary N, Valabhji J (2015), Management of hypertriglyceridaemia-induced acute pancreatitis in pregnancy. J Matern Fetal Neonatal Med. 2015 28 954-958

Valabhji J, Johnston DG, Bellamy M, Davies W, Bain BJ, (2000), Systemic mastocytosis can present as unexplained loss of consciousness. Journal of the Royal Society of Medicine 93:141-142. IF: 1.411

Valabhji J, Robinson S, Elkeles RS, (2000), Hepatic abscess in a diabetic patient. Postgraduate Medical Journal 76 (902): 797-798. IF: 1.939

Private practice

Visit the Imperial private Healthcare website